First test focused on risk assessment of Acute Kidney Injury in pediatric patients
BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation
May 2019
Read More
NGAL
NGAL
As early AKI detection counts

The NGAL Test – first diagnostic acute kidney injury biomarker which can be measured in both human urine and plasma. NGAL measurements are useful in the diagnosis of acute kidney injury which may lead to acute renal failure.

The NGAL Test is not available in the USA for in vitro diagnostic use.

We have also launched a unique range of NGAL human an animal antibodies and ELISA kits for research on nephrotoxity.

LEARN MORE HERE
Antibodies
ANTIBODIES AND IMMUNOASSAYS

Enter our world of high quality monoclonal antibodies and immunoassays. We offer highly specific antibodies for pharmaceutical research and in vitro diagnostic test.

Several Antibodies from BioPorto Diagnostics highly cited under the Antibodyshop brand.

We have unique antibodies in areas such as diabetes and obesity, allergy and immune deficiency.

 

LEARN MORE HERE
Lateral flow
Bulk antibodies upon request

Our bulk antibodies solutions mean always competitive pricing and world class delivery service. Throughout years of listening to our customers, we developed ability to offer flexible solutions.

Click on the slide and check our comprehensive list of monoclonal antibodies.

 

LEARN MORE HERE